Summit Securities Group’s CytoMed Therapeutics GDTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,407
Closed -$19K 562
2023
Q3
$19K Buy
+5,407
New +$19K ﹤0.01% 217